Trk-IN-9

CAS No. 2758623-12-8

Trk-IN-9( —— )

Catalog No. M35671 CAS No. 2758623-12-8

Trk-IN-9 (Compound 12) is a potent inhibitor of TRK that inhibits the proliferation of Km-12 cell lines and induces apoptosis in a concentration-dependent manner.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 144 Get Quote
5MG 217 Get Quote
10MG 321 Get Quote
25MG 523 Get Quote
50MG 748 Get Quote
100MG 981 Get Quote
500MG 2601 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Trk-IN-9
  • Note
    Research use only, not for human use.
  • Brief Description
    Trk-IN-9 (Compound 12) is a potent inhibitor of TRK that inhibits the proliferation of Km-12 cell lines and induces apoptosis in a concentration-dependent manner.
  • Description
    Trk-IN-9 (Compound 12) is a potent inhibitor of TRK. Trk-IN-9 inhibits the proliferation of Km-12 cell lines. Trk-IN-9 induces the apoptosis of Km-12 cells in a concentration-dependent manner. Trk-IN-9 inhibits the phosphorylation of TRK to block downstream pathways. Trk-IN-9 has the potential for the research of NTRK-fusion cancers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | Trk receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2758623-12-8
  • Formula Weight
    454.93
  • Molecular Formula
    C23H24ClFN6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C=1N=C(NCC2=CC(F)=CC=C2)C(Cl)=CN1)C3=CC(C(N[C@@H]4CCCNC4)=O)=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wu T, et al. Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold. Eur J Med Chem. 2022;230:114096.?
molnova catalog
related products
  • Benzyl selenocyanate

    Benzyl selenocyanate is a chemopreventive agent that effectively inhibits chemically induced tumors at both initiation and postinitiation stages in animal models.

  • Voreloxin hydrochlor...

    Voreloxin hydrochloride is a potent inhibitor of Topoisomerase II with broad-spectrum anti-tumor activity.

  • Methyl-4-oxoretinoat...

    Methyl-4-oxoretinoate is a synthetic retinoid compound with anticancer compounds that can induce differentiation and apoptosis in cancer cells.Methyl-4-oxoretinoate is used in the treatment of acne, psoriasis, and other skin disorders.Methyl-4-oxoretinoate has the potential to be used in the treatment of a variety of ocular disorders such as age-related macular degeneration. related macular degeneration).